(2) | (47) | " (5) | # (2) | $ (1) | 0 (43) | 1 (528) | 2 (598) | 3 (345) | 4 (27) | 5 (21) | 6 (14) | 7 (7) | 8 (3) | 9 (4) | < (49) | A (336) | B (71) | C (270) | D (140) | E (194) | F (157) | G (462) | H (72) | I (178) | J (46) | K (72) | L (87) | M (209) | N (154) | O (62) | P (276) | Q (10) | R (113) | S (501) | T (561) | U (134) | V (38) | W (308) | X (9) | Y (15) | Z (8) |   (1) | Д (1) | П (1) | С (1) | إ (1) | (2) | (1)
Title Last update
34-6.07 Digital Adherence Tool Pillbox Technical Information Note Tue, 01/24/2023 - 03:02
34-6.06 TB Medicines Dashboard Tue, 01/24/2023 - 03:02
34-6.05 TB Procurement & Market-Shaping Action Team Meeting Report Tue, 01/24/2023 - 03:01
34-6.04_Early evaluation of ultra-portable X-ray system Tue, 01/24/2023 - 03:01
34-6.03_Evaluation of five artificial intelligence algorithms Tue, 01/24/2023 - 03:00
34-6.02 CXR and AI Guide Tue, 01/24/2023 - 03:00
34-6.01 TB REACH Case for Investment Tue, 01/24/2023 - 02:59
34-5.4 Global Fund Session Tue, 01/24/2023 - 02:57
34-5.3_Stop TB Partnership work on maximizing the impact of Global Fund investments in TB Tue, 01/24/2023 - 02:57
34-5.2 STP Community & Developing Country NGO Delegation Position Paper on Global Fund_working document__ Tue, 01/24/2023 - 02:56
34-5.1_GFSession_Tuberculosis Never a Priority, Always a Killer (disease split) Tue, 01/24/2023 - 02:56
34-4.9_TB at the centre of PPR Tue, 01/24/2023 - 02:41
34-4.8 Innovations for Tackling Tuberculosis in the Time of COVID-19_SpeakerBios Tue, 01/24/2023 - 02:40
34-4.7 Innovations for Tackling Tuberculosis in the Time of COVID-19_Pt.2 Tue, 01/24/2023 - 02:40
34-4.6 Innovations for Tackling Tuberculosis in the Time of COVID-19_Pt.1 Tue, 01/24/2023 - 02:40
34-4.5 TB at the centre of airborne pandemic preparedness and response Tue, 01/24/2023 - 02:39
34-4.4_ETTI_TechSheet_Personal Respirators Tue, 01/24/2023 - 02:39
34-4.3_ETTI_TechSheet_Disinfecting room air with GUV Tue, 01/24/2023 - 02:39
34-4.2_COVID & TB Integrated Contact Investigation Tue, 01/24/2023 - 02:38
34-4.1_COVID-TB Simultaneous Integrated Testing Tue, 01/24/2023 - 02:38
34-4.11 Forum on Microbial Threats Innovations for Tackling Tuberculosis Tue, 01/24/2023 - 02:41
34-4.10_Forum on Microbial Threats Innovations for Tackling Tuberculosis in the time of covid-19 Tue, 01/24/2023 - 02:41
34-3.5_Communities, Rights and Gender_Progress and Achievements Presentation Tue, 01/24/2023 - 02:30
34-3.4_Enabling TB Affected Community Engagement in TGF C19RM_Report on STP CS support package Tue, 01/24/2023 - 02:31
34-3.3 Stop TB Stigma Assessment Tool Implementation Handbook Tue, 01/24/2023 - 02:29
34-3.2_OneImpact CLM Conceptual and Implementation Framework FN Tue, 01/24/2023 - 02:29
34-3.1 A Deadly Divide TB Commitments Vs. TB Realities Tue, 01/24/2023 - 02:28
34-2.2_UNHLM Targets and Commitments for 2022 [.pdf] Wed, 01/18/2023 - 05:59
34-2.1_UNHLM Targets and Commitments GA [.pdf] Wed, 01/18/2023 - 05:53
34-1.4_Stop TB Partnership KPI Results 2020 updated&final [.pdf] Wed, 01/18/2023 - 05:52
34-1.3 Report of the Executive Director Wed, 01/18/2023 - 05:51
34-1.2 Report on Actions of DPs_33rd Board Meeting [.pdf] Wed, 01/18/2023 - 05:49
34-1.1_Draft Board Agenda 20210926 [.pdf] Wed, 01/18/2023 - 05:49
34-0.3 List of Participants_draft 28 Sept [.pdf] Wed, 01/18/2023 - 05:35
34-0.2_List of Documents [.pdf] Wed, 01/18/2023 - 05:34
34-0.1_Virtual Guidance Note to the Board [.pdf] Wed, 01/18/2023 - 05:33